People: ACTIVE Biotech AB (ACTI.ST)
53.50SEK
20 May 2013
0.50kr (+0.94%)
53.00kr
--
53.75kr
52.25kr
53,071
125,143
69.50kr
37.00kr
Arnhog, Mats
Brief Biography
Mr. Mats Arnhog has been Chairman of the Board of Directors of Active Biotech AB since 2003. He has been Member of the Company’s Board since 2000. He also serves as Member of the Active Biotech’s Nomination Committee. Mr. Arnhog chairs the Boards of Directors of MGA Holding AB with subsidiaries and Rederi AB Sea-Link. He is also Board Member of Brofagel Support AB, and serves as Member of Advisory Board of the Stockholm School of Economics (Handelshogskolan i Stockholm). Mr. Arnhog holds a degree in Economics and Business Administration as well as an Honorary Doctorate of Philosophy in Economics from Handelshogskolan i Stockholm.
Basic Compensation
| Total Annual Compensation, SEK | Long-Term Incentive Plans, SEK | All Other, SEK | Fiscal Year Total, SEK |
|---|---|---|---|
| 250,000 | -- | -- | 250,000 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Mats Arnhog |
250,000 |
Tomas Leanderson |
5,190,000 |
Hans Kolam |
-- |
Helen Tuvesson |
-- |
Goran Forsberg |
-- |
Karin Hallbeck |
-- |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
